Divergent effects of topical deferoxamine treatment on skin and cancer cells uncovers its potential as a safe radioprotective agent in oncological applications.

These findings were further supported by IF staining of Ki-67, which showed a trend toward reduced cancer cell proliferation in the DIDP-treated group, although the difference was not statistically significant.

also in 53,322 other papers